MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Ovarian cancer diagnosis and treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,301 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,301 works in the cohort · of 4,299,418page 29 of 47

Labels cover 7 of 2,301 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,301 of 2,301 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
#1015 Mirvetuximab soravtansine demonstrates longer overall survival and progression-free survival by prior lines of therapy vs chemotherapy in platinum-resistant ovarian cancer and high folate receptor alpha expression in the MIRASOL trial
Toon Van Gorp, Renaud Sabatier, Gottfried E. Konecny, J. B. Gordon, Sandro Pignata, Nicoletta Colombo +14 more
2023· article· en· International Journal of Gynecological Cancer· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
aboutno affunlabeled
Synchrotron Imaging of Ovaries Ex Vivo
Upekha Basnayaka, Dean Chapman
2016· article· en· Journal of Fertilization In Vitro - IVF-Worldwide Reproductive Medicine Genetics & Stem Cell Biology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
[Surgical treatment of advanced epithelial ovarian cancer].
Arturas Inčiūra, Elona Juozaitytė, Rūta Jolanta Nadišauskienė, Vida Marija Čigriejienė, Skirmantas Kajėnas, Daiva Vaitkienė +2 more
2004· article· en· PubMed· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
venueno affno abstractunlabeled
Two-Port Laparoscopic Removal of Large Ovarian Cystadenoma
Greg Marchand, Katelyn Sainz, Stacy Ruther, Ali Azadi, Kelly Ware, Giovanna Brazil +7 more
2021· article· en· Journal of Obstetrics and Gynaecology Canada· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Mirvetuximab soravtansine: an oasis in the desert?
Luisa Bonilla, Lawrence Kasherman, Luís Manso, Ainhoa Madariaga
2024· editorial· en· International Journal of Gynecological Cancer· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Intraperitoneal Chemotherapy
Walter H. Gotlieb
2010· review· en· International Journal of Gynecological Cancer· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affvenueno abstractunlabeled
In Response
John Thiel
2012· letter· en· Journal of Obstetrics and Gynaecology Canada· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
← previousnext →

How this was built: Screen · Findings · About